Thoratec Presentation at J.P. Morgan Conference to be Webcast

PLEASANTON, Calif., Jan. 6 Thoratec Corporation(Nasdaq: THOR), a world leader in device-based mechanical circulatory supporttherapies to save, support and restore failing hearts, said today that it willbe participating in the 27th Annual J.P. Morgan Healthcare Conference onWednesday, January 14.

Gary Burbach, president and chief executive officer, will provide anupdate on the company, beginning at 9 a.m., Pacific Standard Time (12 p.m.Eastern Standard Time).

The presentation will be available through the conference website athttp://metameetings.com/webcasts/jpmorgan/healthcare09/directlink?ticker=THORor on the company's website at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heartfailure. The company's product lines include the Thoratec(R) VAD (VentricularAssist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) withnearly 12,000 devices implanted in patients suffering from heart failure.Additionally, its International Technidyne Corporation (ITC) division suppliespoint-of-care blood testing and skin incision products. Thoratec isheadquartered in Pleasanton, California. For more information, visit thecompany's web sites at http://www.thoratec.com or http://www.itcmed.com.

SOURCE Thoratec Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...